Elite Pharmaceuticals Inc
OTC:ELTP

Watchlist Manager
Elite Pharmaceuticals Inc Logo
Elite Pharmaceuticals Inc
OTC:ELTP
Watchlist
Price: 0.74 USD 10.46% Market Closed
Market Cap: 790.5m USD

Intrinsic Value

The intrinsic value of one ELTP stock under the Base Case scenario is 0.14 USD. Compared to the current market price of 0.74 USD, Elite Pharmaceuticals Inc is Overvalued by 81%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ELTP Intrinsic Value
0.14 USD
Overvaluation 81%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Elite Pharmaceuticals Inc

Valuation History Unavailable

Historical valuation for ELTP cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%
Compare ELTP to

Fundamental Analysis

Company Overview
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about ELTP?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Elite Pharmaceuticals Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Elite Pharmaceuticals Inc

Current Assets 48m
Cash & Short-Term Investments 8.3m
Receivables 18.5m
Other Current Assets 21.3m
Non-Current Assets 42.7m
Long-Term Investments 461.6k
PP&E 13.9m
Intangibles 7.2m
Other Non-Current Assets 21.1m
Efficiency

Free Cash Flow Analysis
Elite Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Elite Pharmaceuticals Inc

Revenue
70m USD
Cost of Revenue
-39.1m USD
Gross Profit
30.9m USD
Operating Expenses
-18.7m USD
Operating Income
12.2m USD
Other Expenses
-30.2m USD
Net Income
-18m USD
Fundamental Scores

ELTP Profitability Score
Profitability Due Diligence

Elite Pharmaceuticals Inc's profitability score is 62/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROIC
Positive Gross Profit
Exceptional 3-Years Revenue Growth
Positive 3-Year Average ROE
62/100
Profitability
Score

Elite Pharmaceuticals Inc's profitability score is 62/100. The higher the profitability score, the more profitable the company is.

ELTP Solvency Score
Solvency Due Diligence

Elite Pharmaceuticals Inc's solvency score is 85/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Low D/E
Short-Term Solvency
85/100
Solvency
Score

Elite Pharmaceuticals Inc's solvency score is 85/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ELTP Price Targets Summary
Elite Pharmaceuticals Inc

There are no price targets for ELTP.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Elite Pharmaceuticals Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for ELTP is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

ELTP Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one ELTP stock?

The intrinsic value of one ELTP stock under the Base Case scenario is 0.14 USD.

Is ELTP stock undervalued or overvalued?

Compared to the current market price of 0.74 USD, Elite Pharmaceuticals Inc is Overvalued by 81%.

Back to Top